Adaptogens for Dogs: What Canine Studies Actually Show

What are adaptogens for dogs?

Adaptogens are botanicals or fungi traditionally described as substances that help an organism respond to physical or psychological stress. In practical terms, the label is used for ingredients such as ashwagandha, reishi, rhodiola, and some other herbs or mushrooms.

The term comes from traditional herbal medicine and later pharmacology. It is not a veterinary diagnosis, a legally protected supplement category, or proof that an ingredient has been tested in dogs. A product can use the word “adaptogen” even when its canine evidence is thin.

For dogs, the proposed idea is that an adaptogen may influence stress signaling, inflammation, antioxidant defenses, or immune activity without acting as a single-purpose sedative. That broad theory is appealing, especially for owners facing both anxiety and recurring health concerns. The problem is that each ingredient has its own chemistry, extract quality, dose, and evidence.

The HPA axis in plain language

The hypothalamic-pituitary-adrenal axis, often shortened to the HPA axis, is a communication system linking the brain and adrenal glands. It helps coordinate the body’s response to stress.

A simplified sequence looks like this:

1. The brain detects a stressor.
2. The hypothalamus and pituitary send hormonal signals.
3. The adrenal glands release cortisol and other stress-related hormones.
4. The body adjusts heart rate, energy use, alertness, digestion, and immune activity.

Cortisol is useful during a short-lived challenge. Problems arise when stress responses are frequent, poorly controlled, or caused by an untreated medical or behavioral condition. A cortisol measurement can tell researchers something about one part of the stress response, but it cannot diagnose anxiety by itself.

That distinction matters. A lower cortisol result does not automatically mean a dog feels calm, sleeps better, stops destroying doors, or has recovered from separation anxiety.

What does “immune modulation” mean?

Immune modulation means changing immune activity in a measured direction. It does not necessarily mean “boosting” immunity.

A dog with a healthy immune system does not need every immune pathway pushed higher. Some immune responses protect against threats; others can contribute to inflammation. A study that finds a change in one cytokine, antibody measurement, or immune-cell response has identified a biological signal. It has not necessarily shown that the dog will have fewer infections or recover faster.

That is why we should use phrases such as immune-related measurement or vaccine-associated antibody response when describing the current research. “Immune boosting” sounds more certain than the evidence allows.

For broader context on mushroom extracts, beta-glucans, product quality, and questions to raise with a veterinarian, see this science-based guide to medicinal mushrooms for dogs.

How might adaptogens affect stress hormones in dogs?

The best canine evidence in the supplied research concerns a small ashwagandha trial in older Labradors. It suggests a change in serum cortisol after 60 days, but it does not establish that ashwagandha normalizes the HPA axis or treats clinical anxiety.

In the randomized, double-blind, placebo-controlled study, 20 apparently healthy, obese Labradors aged at least 8 years received either a standardized ashwagandha root extract at 15 mg/kg/day or starch placebo. At day 60, the reported serum cortisol value was 1.88 µg/dL in the extract group versus 2.75 µg/dL in the placebo group, with a reported between-group p value below 0.001. The study was conducted in client-owned geriatric dogs, which gives it more real-world relevance than a purely laboratory experiment, but the sample was small and limited to one breed and age group. The paper also uses different cortisol units in its methods and results, so the reported endpoint should be read exactly as presented rather than converted into a new percentage. See the peer-reviewed geriatric dog ashwagandha trial for the full methods and results.

The study also reported changes in selected cytokines. Its detailed results describe the Nrf-2 and NFκB group differences as nonsignificant, and the authors did not establish infection prevention or correction of an immune disorder. That makes the study useful as an early biomarker signal, not as proof that ashwagandha broadly restores immune health.

Why the cortisol finding matters—and what it cannot tell you

The cortisol result matters because it was generated in dogs, used a placebo comparator, and measured a defined physiological endpoint. Those are meaningful strengths.

It cannot tell us:

• whether the dogs had anxiety;
• whether their behavior improved;
• whether the extract works in puppies, small breeds, pregnant dogs, or dogs with liver or endocrine disease;
• whether the effect lasts after supplementation stops;
• whether the extract is better than CBD;
• whether a lower cortisol value is always desirable.

The requested CSMI benchmark cannot be calculated from this trial. CSMI is not a validated canine scale with a published formula, weighting system, cutoff, or reference population. The study did not report CSMI, and it did not provide the exact treatment-group baseline value needed to calculate a defensible baseline-to-endpoint improvement.

A responsible article should leave that score blank rather than turn one cortisol endpoint into a made-up index.

What about a four-week ashwagandha case study?

A frequently repeated content request is a case involving one dog whose separation anxiety improved after four weeks of ashwagandha. The evidence supplied for this article does not contain a qualifying original case report.

The available ashwagandha trial involved groups of geriatric Labradors over 60 days. It did not document one dog’s diagnosed separation anxiety, and it did not establish a four-week behavioral outcome. That means we cannot present the requested story as a published case.

This is more than a technical distinction. A group biomarker result and an individual behavior story answer different questions. A cortisol measurement can be collected under controlled conditions. Separation anxiety requires a behavioral history, observation of the dog’s response to departure, assessment of household routines, and consideration of medical contributors. The AAHA canine and feline behavior management guidelines support structured behavioral assessment and reward-based behavior modification; they do not endorse a general adaptogen protocol.

Which adaptogens have canine evidence?

Ashwagandha and reishi currently offer the clearest canine signals in the supplied research, but they answer different questions.

Ashwagandha has been studied in older dogs with cortisol and selected inflammatory or antioxidant-related measurements. Reishi has been studied in healthy beagles with immune assays, including an antibody response after vaccination. Neither ingredient has strong canine evidence for treating both anxiety and immune weakness in the same population.

Ashwagandha for dogs: what the study showed

Ashwagandha, or Withania somnifera, is a botanical root traditionally used in Ayurvedic medicine. In dogs, the most relevant supplied trial used a standardized root extract at a research dose of 15 mg/kg/day for 60 days.

The day-60 cortisol difference is promising as a physiological observation. It does not establish a general owner dose because:

• the extract’s standardization matters;
• the dogs were older Labradors;
• the study population was small;
• the result was measured at a specific endpoint;
• the paper does not establish a safe range for all dogs;
• the trial was not a separation-anxiety study.

Owners should also avoid assuming that a human ashwagandha capsule is interchangeable with a veterinary formulation. Root powder, concentrated extract, alcohol extract, and multi-ingredient blends can differ substantially.

Reishi mushroom for dogs: what the study showed

Reishi, or Ganoderma lucidum, is a medicinal mushroom rather than a traditional herb. In a 28-day feeding experiment involving 40 healthy adult beagles, researchers tested 0, 5, 10, or 15 mg/kg/day of a reishi ingredient specified as at least 70% beta-glucans.

At the 15 mg/kg/day level, the day-14 rabies-specific IgG area-under-the-curve fold-change measure was 3.21 versus 1.50 in controls. This was a laboratory antibody-response measure collected seven days after vaccination, not a clinical protection rate. The study also found mixed results: fecal IgA and stimulated TNF-α production were unaffected, while some cellular findings were trends. The full study is available as the original canine reishi feeding experiment.

The practical interpretation is narrow: reishi may influence selected immune measurements in healthy dogs under defined research conditions. It has not been shown to prevent infections, treat diagnosed immune weakness, or calm anxious behavior.

A simple evidence map

This comparison is an evidence inventory, not a winner’s table. The studies differ in ingredient, extract, dose, dog population, stressor, duration, and outcome. Cross-study numbers cannot be placed on a common performance scale without a validated method.

Are adaptogens safer than CBD for dogs?

The current evidence does not support saying that adaptogens are safer or more effective than CBD across dogs. It supports a more useful conclusion: both categories require ingredient-specific review, and neither has a universal safety profile.

CBD research in dogs is also more nuanced than many online claims suggest. In a randomized experiment using approximately 4 mg/kg of THC-free CBD, healthy dogs had lower mean serum cortisol after a short car journey than placebo-treated dogs: 40.7 ± 4.3 ng/mL versus 56.7 ± 6.0 ng/mL. The same experiment did not detect a significant post-separation cortisol difference or a treatment effect on IgA. The peer-reviewed CBD stress experiment in dogs did not study dogs diagnosed with clinical separation anxiety.

A separate randomized safety study gave healthy adult Labradors, beagles, and Norfolk terriers approximately 4 mg/kg/day of one THC-free CBD formulation for 26 weeks, followed by a four-week washout. The researchers reported good tolerability in that tested population and formulation, alongside transient alkaline phosphatase elevations. That finding cannot be generalized to every CBD product, every dog, or every medical condition. The long-term canine CBD safety study provides the relevant study details.

The same discipline applies to adaptogens. A plant’s natural origin does not remove the possibility of sedation, gastrointestinal upset, allergic reactions, altered bleeding risk, or drug interactions. Narda G. Robinson, DVM, DO, FAAMA, writes that “Adding herbs to the mix has the potential to affect plasma concentrations of coadministered pharmaceuticals.” Her veterinary reference also lists potential reishi interactions involving anticoagulant, antiplatelet, immunosuppressant, and other medicines. Read the Merck Veterinary Manual guidance on herbal medicine before treating an herb as harmless.

What does the research say about CBD legality?

Regulatory questions depend on the country, state, province, product, and intended use.

In the United States, the FDA states that cannabis has not been approved for any use in animals and that adding CBD or THC to animal food for interstate commerce is prohibited. That is a statement about federal regulatory status and animal-food commerce, not a complete state-by-state analysis. The FDA’s current animal CBD and cannabis guidance should be checked alongside local rules and veterinary advice.

Health Canada’s checked consultation page states that no veterinary drugs containing cannabis, including CBD, are authorized, while distinguishing hemp-based veterinary health products. A consultation document should not be read as an enacted new pathway. The Health Canada veterinary CBD consultation explains that distinction.

Neither regulatory uncertainty nor marketing frustration proves that adaptogens are safer. It means owners should ask better questions about product identity, testing, dose, interactions, and veterinary oversight.

How should you introduce an adaptogen to a dog?

The safest starting point is a veterinary review of the dog, the goal, the product, and the medication list. There is no broadly validated canine protocol that tells every owner which adaptogen to use, how quickly to increase it, or how long to continue.

A cautious discussion with a veterinarian can follow this sequence.

1. Define the problem before choosing an ingredient

   Write down what you want to change. “Immune weakness” may describe recurring infections, poor appetite, slow wound healing, gastrointestinal signs, or simply a dog that seems tired. “Anxiety” may describe separation distress, noise sensitivity, pain, cognitive decline, or an environmental problem.

   The cause matters because an herb cannot correct every cause. A painful dog may need an orthopedic or dental evaluation. A dog with sudden behavior change may need a medical workup. A dog with severe separation distress may need a structured behavior plan and, in some cases, prescription medication.

2. Bring a complete product and medication list

   Include prescriptions, flea and tick products, vitamins, mushroom powders, calming chews, and human supplements. Tell the veterinarian the exact label, not just the product name.

   This is especially important for senior dogs and dogs taking anticoagulants, antiplatelet drugs, immunosuppressants, seizure medications, heart medications, thyroid medication, or drugs processed through the liver. The interaction concern is not proof that a problem will occur. It is a reason to screen before combining ingredients.

3. Choose one clearly identified ingredient

   Starting several new supplements at once makes the result impossible to interpret. A product should identify the botanical or mushroom species, plant part, extract type, concentration, serving amount, and lot information when available.

   A blend can be convenient, but it makes adverse reactions and benefits harder to trace. Ask whether the label’s serving size is based on body weight and whether the listed amount refers to the raw ingredient or a concentrated extract.

4. Do not copy a research dose without matching the study

   The ashwagandha and reishi research doses described here belong to specific extracts, populations, and protocols. They are not general instructions.

   A research dose of 15 mg/kg/day of one standardized root extract cannot be assumed to equal 15 mg/kg/day of a different powder. The same problem applies to reishi extracts with different beta-glucan content, fruiting-body ratios, or extraction methods.

5. Track behavior and health observations

   For anxiety, record departure time, pacing, vocalization, destruction, appetite, sleep, recovery after reunion, and response to training. For immune-related concerns, record appetite, stool, energy, skin changes, infections, medications, and veterinary findings.

   A weekly video or written log is often more useful than a vague impression that a dog “seems better.” It also helps a veterinarian decide whether the supplement is worth continuing.

6. Stop and contact the veterinarian if concerning signs appear

   Potential warning signs can include repeated vomiting or diarrhea, marked sedation, agitation, weakness, collapse, unusual bruising or bleeding, facial swelling, breathing difficulty, yellowing of the gums or eyes, or a clear worsening of behavior.

   Dogs with serious illness, puppies, pregnant or nursing dogs, and dogs receiving multiple medications require extra caution because the available canine evidence does not define their safety boundaries.

A supplement should sit inside a care plan. For anxiety, pair any supplement discussion with predictable routines, gradual departure work, enrichment, and reward-based training. The canine gut-brain connection guide offers related context on stress behavior and nutritional support, while the science review of quercetin for dogs shows why proposed mechanisms and proven clinical outcomes should be kept separate.

Which adaptogen fits your dog’s situation?

No supplement can be selected responsibly from a symptom label alone, but the evidence can help organize the discussion.

• Older dog with a stress or aging concern: Ashwagandha has the most relevant supplied canine cortisol study, but that study involved geriatric Labradors and did not test anxiety treatment.
• Healthy dog being evaluated for immune-related support: Reishi has canine immune-assay research, including a vaccine-associated antibody measurement, but it has not been shown to prevent infections or correct immune disease.
• Dog with diagnosed separation anxiety: Start with behavioral and medical assessment. Supplements may be discussed as an adjunct, but the current evidence does not establish ashwagandha or reishi as a replacement for proven multimodal care.
• Dog already taking several medicines: Begin with an interaction review. “Natural” does not mean pharmacologically inactive.
• Puppy, pregnant dog, nursing dog, or dog with serious illness: Do not extrapolate adult research-dog results. Ask the veterinarian for a condition-specific recommendation.

The most useful selection question is not “Which herb is strongest?” It is “Which defined problem are we trying to address, what evidence exists for this dog, and how will we tell whether the plan is helping?”

Frequently Asked Questions

What should you take away about adaptogens for dogs?

Adaptogens are a useful research category, but they are not a shortcut around diagnosis or careful monitoring. Ashwagandha has early evidence for a lower cortisol endpoint in a small group of geriatric Labradors. Reishi has evidence for selected immune measurements in healthy beagles. Those findings are worth discussing with a veterinarian, while their limits deserve equal attention.

CBD also has canine research, including a positive acute car-travel cortisol result and a longer safety study of one THC-free formulation. That evidence does not prove CBD works for every anxious dog, and the absence of a head-to-head comparison means adaptogens cannot honestly be described as superior.

The safest path is to define the dog’s problem, review medical and behavioral causes, choose one clearly identified ingredient if a veterinarian agrees, and track meaningful outcomes. A dosage chart can organize research doses, but it cannot replace individualized veterinary guidance. Use this article as a starting point for that conversation, then ask your veterinarian whether an adaptogen belongs in your dog’s care plan.